Related references
Note: Only part of the references are listed.Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse
Alain P. Vicari et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hosts
Chih-Wen Tseng et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients
Paola Nistico et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Use of tumour-responsive T cells as cancer treatment
Mary L. Disis et al.
LANCET (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Optimized DNA vaccines to specifically induce therapeutic CD8 T cell responses against autochthonous breast tumors
Hyun-Il Cho et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Combined modality immunotherapy and chemotherapy: a new perspective
Rupal Ramakrishnan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Combination chemotherapy and ALVAC-CEA/B7.1 vaccine in patients with metastatic colorectal cancer
Howard L. Kaufman et al.
CLINICAL CANCER RESEARCH (2008)
Combination of docetaxel and recombinant vaccine enhances T-Cell responses and antitumor activity: Effects of docetaxel on immune enhancement
Charlie T. Garnett et al.
CLINICAL CANCER RESEARCH (2008)
Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy
Lei Zhang et al.
CLINICAL IMMUNOLOGY (2008)
A chitosan hydrogel-based cancer drug delivery system exhibits synergistic antitumor effects by combining with a vaccinia viral vaccine
Hee Dong Han et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Immunological aspects of cancer chemotherapy
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Inhibitory B7-family molecules in the tumour microenvironment
Weiping Zou et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Cancer vaccines: Moving beyond current paradigms
Jeffrey Schlom et al.
CLINICAL CANCER RESEARCH (2007)
Apoptosis induced by the lymphocyte effector molecule perforin
Paul Bolitho et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Peptide vaccine given with a Toll-like receptor agonist is effective for the treatment and prevention of spontaneous breast tumors
Pilar Nava-Parada et al.
CANCER RESEARCH (2007)
Nuclear translocation of endonuclease G and apoptosis-inducing factor during acetaminophen-induced liver cell injury
Mary Lynn Bajt et al.
TOXICOLOGICAL SCIENCES (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer
PM Arlen et al.
CLINICAL CANCER RESEARCH (2006)
Granule-mediated killing by granzyme B and perforin requires a mannose 6-phosphate receptor and is augmented by cell surface heparan sulfate
K Veugelers et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
SJ Antonia et al.
CLINICAL CANCER RESEARCH (2006)
Leveraging the activity of tumor vaccines with cytotoxic chemotherapy
LA Emens et al.
CANCER RESEARCH (2005)
Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapy
JG Gribben et al.
CLINICAL CANCER RESEARCH (2005)
Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations
BA He et al.
ONCOGENE (2005)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination
CJ Wheeler et al.
CLINICAL CANCER RESEARCH (2004)
Granzyme-mediated cytotoxicity does not involve the mannose 6-phosphate receptors on target cells
R Dressel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A clathrin/dynamin- and mannose-6-phosphate receptor-independent pathway for granzyme B-induced cell death
JA Trapani et al.
JOURNAL OF CELL BIOLOGY (2003)
An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53
EY Nikitina et al.
GENE THERAPY (2002)
Endonuclease G: a mitochondrial protein released in apoptosis and involved in caspase-independent DNA degradation
G van Loo et al.
CELL DEATH AND DIFFERENTIATION (2001)
Characterization of CD8(+) cytotoxic T lymphocyte/tumor cell interactions reflecting recognition of an endogenously expressed murine wild-type p53 determinant
MH Ryan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2001)
Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members Bid and Bax
JA Heibein et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Initiation of apoptosis by granzyme B requires direct cleavage of Bid, but not direct granzyme B-mediated caspase activation
VR Sutton et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis
B Motyka et al.
CELL (2000)